Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-020073
Filing Date
2019-07-23
Accepted
2019-07-23 11:39:19
Documents
1
Period of Report
2019-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8215
  Complete submission text file 0000899243-19-020073.txt   9946
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Reporting) CIK: 0001121404 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38978 | Film No.: 19967156
SIC: 2834 Pharmaceutical Preparations

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

EIN.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations